BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M; ItalKid-HUS Network. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network. J Pediatr 2021:S0022-3476(21)00630-2. [PMID: 34197890 DOI: 10.1016/j.jpeds.2021.06.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tarr PI, Freedman SB. Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 2022;38:30-8. [PMID: 34871193 DOI: 10.1097/MOG.0000000000000798] [Reference Citation Analysis]
2 Costigan C, Wildes DM, Riordan M, Awan A, Gorman KM. Why exclude children with Shiga toxin genotype 1 alone from hemolytic uremic syndrome screening? J Pediatr 2021:S0022-3476(21)00752-6. [PMID: 34358531 DOI: 10.1016/j.jpeds.2021.07.060] [Reference Citation Analysis]